Facebook Linkedin Twitter
Inside Precision Medicine Cullinan Nets $280M Investment and Targets CD19 in Lupus

In vitro assays

immune system
News & Features

Cullinan Nets $280M Investment and Targets CD19 in Lupus

Malorye Branca -
0
Bladder Cancer
News & Features

Researchers Learn Why Cisplatin-Based Chemotherapy Works Best in Advanced Bladder Cancer

Chris Anderson -
0
Bowel cancer
News & Features

Bioprinted Bowel Cancer Spheroids Poised to Advance Targeted Treatments

Chris Anderson -
0
antibodies
News & Features

CDMO Services: Enabling Faster Time to Results and Market

Kathy Vuksanaj -
0
Virus with RNA molecule inside. Viral variant concept. 3D rendered illustration.
Coronavirus

Amilorides Offer New Anti-Viral Mechanism to Target COVID-19

Malorye Branca -
0
3d illustration of a cancer cell in the process of mitosis
News & Features

Droplets That Regulate Chromatin Structure Play Role in Cancer Development

Anjali A. Sarkar, PhD -
0
life science professionals
Molecular Dx

Sponsored: Is your assay sustainable?

API User -
0
ArcherDx and Illumina to Partner, Co-Market In Vitro Diagnostics
Molecular Dx

ArcherDx and Illumina to Partner, Co-Market In Vitro Diagnostics

Alex Philippidis -
0
CVS Enters Precision Health Arena with Transform Oncology Care Launch
Molecular Dx

CVS Enters Precision Health Arena with Transform Oncology Care Launch

Chris Anderson -
0
Neuroblastoma cell line labeled with fluorescent molecules
News & Features

Potential Genetic Drug Target for Neuroblastoma Identified

Chris Anderson -
0
123...8Page 1 of 8

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine